Navigation Links
Alere Inc. Declares Cash Dividend on Its Series B Convertible Perpetual Preferred Stock

WALTHAM, Mass., March 1, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).  The dividend is payable on April 16, 2012 to holders of record of Series B stock at the close of business on April 2, 2012. 

Such payment will cover the amount of all dividends accrued from January 1, 2012 through March 31, 2012.

For more information about Alere, please visit our website at

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home.  Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, diabetes, oncology, toxicology and women's health.  Alere is headquartered in Waltham, Massachusetts.


SOURCE Alere Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Alere Inc. Statement Regarding Recommended Increased Cash Offer to Acquire Axis-Shield
2. Alere Inc. Statement Regarding Axis-Shield Offer
3. Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer
4. Alere Inc. Announces $2.1 Billion Credit Facilities
5. Alere Inc. Announces Completion of Consent Solicitations Related to its 9.0% Senior Subordinated Notes due 2016, 8.625% Senior Subordinated Notes due 2018 and 7.875% Senior Notes due 2016
6. Alere Inc. Announces Extension of Consent Solicitations Related to its 9.0% Senior Subordinated Notes Due 2016, 8.625% Senior Subordinated Notes Due 2018 and 7.875% Senior Notes Due 2016 and Increased Consent Fees
7. Alere Inc. Declares Dividend on its Series B Convertible Perpetual Preferred Stock
8. Alere to Attend the Deutsche Bank 36th Annual Health Care Conference on May 4, 2011
9. Alere Inc. Announces First Quarter 2011 Results
10. Alere Earns NCQA Health Information Products Certification for Health Information Line
11. Alere Previews Findings from Key Research Study on Medication Adherence at Integrated Benefits Institute Conference
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015 USP 800 applies ... preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, physician ... The chapter also covers all entities which store, ... hospitals, other healthcare institutions, patient treatment clinics, physicians, ... --> --> What is the ...
(Date:11/25/2015)... Nov. 25, 2015  Mindray Medical ... MR ), a leading developer, ... worldwide, today announced that it will ... of shareholders at the Company,s Hong Kong office ... Prince Edward West Road, Mongkok KL, Hong ...
(Date:11/25/2015)... 2015 Research and Markets ( ) ... - Global Forecast to 2020" report to their ... for 37.21% of the total market share in 2014. ... region is projected to growth at the highest CAGR ... primarily to the fast growing water, industrial gas treatment, ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... ... Charitable giving is at its peak during the holidays. In fact, ... the year totalling over $358 billion in 2014. With more than 1.5 million ... individuals who want to “give back” during the holidays. , “With so many charities ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article ... variables that determine which patients are or are not eligible for bariatric surgery. The ... BMI over 40, are more than 100 pounds overweight, or have a BMI of ...
(Date:11/24/2015)... ... ... DMG Productions announced that they will feature Aphria, Inc., in an upcoming episode ... and show times TBA. , Aphria, Inc., is a publicly traded company incorporated under ... medical marijuana pursuant to the Marijuana for Medical Purposes Regulations (the “MMPR”). , Aphria ...
(Date:11/24/2015)... ... ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, Dec. ... has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls under ... the device regulations. , Come up short in an inspection and the FDA can ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... organization will waive paid entry and parking fees at several of their most ... Mountain in Great Barrington in support of REI’s Black Friday #OptOutside Campaign. The ...
Breaking Medicine News(10 mins):